Mercaptamine oculair
Generic name
Mercaptamine oculair
Brand name
ATC Code
S01XA21
- Dosages
- Side effects in children
- Warnings & precautions in children
- Contra-indications in children
-
Interactions - PK
- Renal impairment
- References
Pharmacokinetics in children
No information is present at this moment.
dose recommendation of formulary compared to licensed use (on-label versus off-label)
No information is present at this moment.
Available formulations
No information is present at this moment.
Dosages
| Treatment of cystine crystal deposits in the cornea in cystinosis |
|---|
|
Renal impaiment in children > 3 months
No information available on dose adjustment in renal impairment.
The complete list of all undesirable drug reactions can be found in the national Summary of Product Characteristics (SmPC) – click here
Side effects in children
Side effects in children are similar (frequency, nature, severity) to those in adults.
The complete list of all contra-indications can be found in the national Summary of Product Characteristics (SmPC) – click here
Contra-indications
No information available on specific contra indications in children.
The complete list of all warnings and precautions can be found in the national Summary of Product Characteristics (SmPC) – click here
Warnings & precautions
No information available on specific warnings and precautions in children.
Interactions
The complete list of all interactions can be found in the national Summary of Product Characteristics (SmPC) – click here
OTHER OPHTHALMOLOGICALS
This pages provides a list of drugs from the same ATC class for comparison. This does not necessarily mean that these drugs are interchangeable.
| OVERIGE MIDDELEN VOOR OOGHEELKUNDIG GEBRUIK | ||
|---|---|---|
| S01XA20 | ||
| S01XA20 | ||
| S01XA20 | ||
| S01XA20 | ||
| S01XA20 | ||
| S01XA20 | ||
| S01XA20 | ||
| S01XA | ||
| Other ophthalmologicals | ||
|---|---|---|
| S01XA20 | ||
| S01XA20 | ||
| S01XA20 | ||
| S01XA20 | ||
| S01XA20 | ||
| S01XA20 | ||
| S01XA20 | ||
| S01XA | ||
References
- Blau, Hoffmann, Leonard and Clarke., Physicians guide to the treatment and follow-up of metabolic diseases, Springer, 2006
- Recordati Rare Diseases, SmPC Cystadrops ( EU/1/15/1049) 16-10-2020, www.geneesmiddeleninformatiebank.nl
- Recordati Rare Diseases, SmPC Cystadrops ( EU/1/15/1049) Rev 10, 08-08-2025, www.ema.europa.eu
Changes
Therapeutic Drug Monitoring
Overdose
